Wall Street analyst price targets, ratings consensus & upside potential · Updated Jun 12, 2026
Last 12 months price action with 12-month analyst target path
As of June 13, 2026, Vermilion Energy Inc. (VET) has a Wall Street consensus price target of $10.74, based on estimates from 10 covering analysts. With the stock currently trading at $11.15, this represents a potential downside of -3.7%. The company has a market capitalization of $1.71B.
Analyst price targets range from a low of $10.74 to a high of $10.74, representing a 0% spread in expectations. The median target of $10.74 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, VET trades at a trailing P/E of -3.7x and forward P/E of 11.2x. Analysts expect EPS to grow +118.7% over the next year.
Total return calculator · dividends reinvested
Calculate ReturnsDollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side revenue, margins, P/E and 10-year returns vs Exxon Mobil Corporation.
Compare NowQuick answers to the most common questions about buying VET stock.
Wall Street's consensus price target for VET is $10.74, -3.7% from its current price of $11.15. The below-market target from 10 analysts suggests limited near-term appreciation.
VET has a consensus rating of "Hold" based on 10 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $10.74 implies -3.7% downside from current levels.
With a forward P/E of 11.2004x, VET trades at a relatively low valuation. The consensus target of $10.74 implies -3.7% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $10.7426 for VET, while the most conservative target is $10.7426. The consensus of $10.74 represents the median expectation. These targets typically reflect 12-month expectations.
VET is moderately covered, with 10 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 4 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VET stock forecast based on 10 Wall Street analysts shows a consensus price target of $10.74, with estimates ranging from $10.7426 (bear case) to $10.7426 (bull case). The median consensus rating is "Hold".
VET trades at a forward P/E ratio of 11.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on VET, with 3 Sell ratings and a price target of $10.74 (-3.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VET analyst price targets range from $10.7426 to $10.7426, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10.74 consensus represents the middle ground.